Adult and Adolescent Vaccines Market to 2018 – Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth

Publisher Name :
Date: 8-Apr-2013
No. of pages: 119

The leading business intelligence provider GBI Research has released its latest research report, entitled “Adult and Adolescent Vaccines Market to 2018 Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth”. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. The report analyzes the market for adult and adolescent vaccines in the US, and the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. The report discusses the global pipeline for adult and adolescent vaccines across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research found that the adult and adolescent vaccines market in the top seven markets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007–2011 historic period. The market is projected to witness a growth of 5.6% during the 2011–2018 forecast period to reach $10.5 billion. The growth in the adult and adolescent vaccines market is driven by increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved for use in people aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19% during the forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011.

Scope

  • Annualized market data for the adult and adolescent vaccines market from 2007 to 2011, forecast forward to 2018
  • Analysis of the adult and adolescent vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan
  • Market characterization of the adult and adolescent vaccines market including market size and cost of vaccination
  • Key drivers and barriers that have a significant impact on the market
  • Coverage of pipeline molecules in various phases of vaccine development
  • Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.
  • Key M&A activities and licensing agreements that have taken place between 2009 and up to November 2012 in the global adult and adolescent vaccines market.

Reasons to buy

  • Align your product portfolio to the markets with the highest growth potential
  • Develop market-entry and market expansion strategies by identifying the potential regions and adult and adolescent vaccines market segments poised for strong growth
  • Create a more specifically-tailored country strategy through the understanding of key drivers and barriers of the global adult and adolescent vaccines market
  • Develop key strategic initiatives by understanding the key focus areas and top-selling products of leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Adult and Adolescent Vaccines Market to 2018 – Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth

Table of Contents

1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12

2 Adult and Adolescent Vaccines Market to 2018 - Introduction 14
2.1 Overview 14

3 Adult and Adolescent Vaccines Market to 2018 - Overview 15
3.1 Vaccine Preventable Diseases 15
3.1.1 Types of Vaccines 16
3.2 Recommendations for Immunization 17
3.2.1 The US 17
3.2.2 Top Five European Countries 19
3.2.3 Japan 20
3.3 Regulatory Framework 21
3.3.1 The US 21
3.3.2 Top Five European Countries 22
3.3.3 Japan 23
3.4 Vaccine Manufacturing Process 24

4 Adult and Adolescent Vaccines Market to 2018 - Market Characterization and Forecast 25
4.1 Revenue Forecast 25
4.2 Market Share by Type of Vaccines 27
4.3 Market Share by Geography 28
4.4 Drivers 28
4.4.1 Adult Vaccines Segment to Drive Future Growth 28
4.4.2 High Unmet Needs 28
4.4.3 Targeting New Diseases Areas for Vaccines Likely To Drive the Market 29
4.4.4 Novel Vaccine Technologies 29
4.5 Restraints 30
4.5.1 Production Capacity Limitations 30
4.5.2 High Initial Capital Investments and Technical Expertise 30
4.5.3 Regulations Delay Vaccine Launch and Acceptance 30

5 Adult and Adolescent Vaccines Market to 2018 - Influenza Vaccines 31
5.1 Disease Overview 31
5.2 Market Forecasts 32
5.2.1 The US 32
5.2.2 Top Five European Countries 34
5.2.3 Japan 36
5.3 Cost of Vaccination 37
5.3.1 The US 37
5.3.2 Top Five European Countries 37
5.3.3 Japan 38
5.4 Pipeline Analysis - Influenza Vaccines 39

6 Adult and Adolescent Vaccines Market to 2018 - Tetanus, Diphtheria and Pertussis Vaccines 42
6.1 Disease Overview 42
6.2 Market Forecasts 43
6.2.1 The US 43
6.2.2 Top Five European Countries 44
6.2.3 Japan 46
6.3 Cost of Vaccination 47
6.3.1 The US 47
6.3.2 Top Five European Countries 47
6.3.3 Japan 48
6.4 Pipeline Analysis - Tetanus, Diphtheria, Pertussis (Td/Tdap) Vaccines 49

7 Adult and Adolescent Vaccines Market to 2018 - Pneumococcal Vaccines 50
7.1 Disease Overview 50
7.2 Market Forecasts 51
7.2.1 The US 51
7.2.2 Top Five European Countries 53
7.2.3 Japan 55
7.3 Cost of Vaccination 56
7.3.1 The US 56
7.3.2 Top Five European Countries 56
7.3.3 Japan 57
7.4 Pipeline Analysis - Pneumococcal Vaccines 58

8 Adult and Adolescent Vaccines Market to 2018 - Meningococcal Vaccines 60
8.1 Disease Overview 60
8.2 Market Forecasts 61
8.2.1 The US 61
8.2.2 Top Five European Countries 62
8.3 Cost of Vaccination 64
8.3.1 The US 64
8.3.2 Top Five European Countries 64
8.4 Pipeline Analysis - Meningococcal Vaccines 65

9 Adult and Adolescent Vaccines Market to 2018 - Human Papilloma Virus Vaccines 66
9.1 Disease Overview 66
9.2 Market Forecasts 67
9.2.1 The US 67
9.2.2 Top Five European Countries 68
9.2.3 Japan 70
9.3 Cost of Vaccination 71
9.3.1 The US 71
9.3.2 Top Five European Countries 71
9.3.3 Japan 72
9.4 Pipeline Analysis - Human Papillomavirus Vaccines 73

10 Adult and Adolescent Vaccines Market to 2018 - Hepatitis Vaccines 75
10.1 Disease Overview 75
10.2 Market Forecasts 76
10.2.1 The US 76
10.2.2 Top Five European Countries 77
10.2.3 Japan 79
10.3 Cost of Vaccination 80
10.3.1 The US 80
10.3.2 Top Five European Countries 80
10.3.3 Japan 81
10.4 Pipeline Analysis - Hepatitis Vaccines 82

11 Adult and Adolescent Vaccines Market to 2018 - Measles, Mumps and Rubella Vaccines 85
11.1 Disease Overview 85
11.2 Market Forecasts 85
11.2.1 The US 85
11.2.2 Top Five European Countries 87
11.3 Cost of Vaccination 88
11.3.1 The US 88
11.3.2 Top Five European Countries 89

12 Adult and Adolescent Vaccines Market to 2018 - Zoster Vaccines 90
12.1 Disease Overview 90
12.2 Market Forecasts 90
12.2.1 The US 90
12.2.2 The UK 91
12.3 Cost of Vaccination 91
12.3.1 The US 91
12.3.2 The UK 92
12.4 Pipeline Analysis - Zoster Vaccines 92

13 Adult and Adolescent Vaccines Market to 2018 - Varicella Vaccines 93
13.1 Disease Overview 93
13.2 Market Forecasts 93
13.2.1 The US 93
13.2.2 Top Five European Countries 94
13.2.3 Japan 96
13.3 Cost of Vaccination 97
13.3.1 The US 97
13.3.2 Top Five European Countries 97
13.3.3 Japan 98
13.4 Pipeline Analysis - Varicella Vaccines 98

14 Adult and Adolescent Vaccines Market to 2018 - Competitive Landscape 99
14.1 Introduction 99
14.2 Major Company Profiles 99
14.2.1 GlaxoSmithKline 99
14.2.2 Sanofi 101
14.2.3 Pfizer 102
14.2.4 Merck 103
14.2.5 Novartis 104

15 Adult and Adolescent Vaccines Market to 2018 - Strategic Consolidations 105
15.1 Deals by Year 105
15.2 Deals by Type 106
15.3 Deals by Value 107
15.4 Deals by Geography 108
15.5 Summary of Major M&A Deals 109
15.6 Summary of Major Licensing Deals 110
15.7 Summary of Major Partnerships 111

16 Adult and Adolescent Vaccines Market to 2018 - Appendix 113
16.1 Market Definitions 113
16.2 Abbreviations 113
16.3 Bibliography 115
16.4 Research Methodology 115
16.4.1 Coverage 115
16.4.2 Secondary Research 116
16.4.3 Primary Research 116
16.4.4 Model for Estimation of Vaccine Market 117
16.5 Geographical Landscape 119
16.6 Pipeline Analysis 119
16.7 Competitive Landscape 119
16.7.1 Expert Panel Validation 119
16.8 Contact Us 119
16.9 Disclaimer 119

List of Tables

Table 1: Adult and Adolescent Vaccines Market to 2018, Vaccine-preventable Diseases, 2012 15
Table 2: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue ($bn), 2007-2011 25
Table 3: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2011-2018 26
Table 4: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue ($m), 2007-2011 33
Table 5: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, The US, Revenue Forecast ($m), 2011-2018 33
Table 6: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 34
Table 7: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 35
Table 8: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue ($m), 2007-2011 36
Table 9: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2011-2018 36
Table 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination ($), 2007-2011 37
Table 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 37
Table 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 37
Table 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 37
Table 14: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination ($), 2007-2011 38
Table 15: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 38
Table 16: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase, 2012 40
Table 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue ($m), 2007-2011 43
Table 18: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2011-2018 43
Table 19: Adult and Adolescent Vaccines Market to 2018, Td/ Tdap, Top Five European Countries, Revenue ($m), 2007-2011 44
Table 20: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2011-2018 45
Table 21: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue ($m), 2007-2011 46
Table 22: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2011-2018 46
Table 23: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination ($), 2007-2011 47
Table 24: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination Forecast ($), 2011-2018 47
Table 25: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination ($), 2007-2011 47
Table 26: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 47
Table 27: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination ($), 2007-2011 48
Table 28: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination Forecast ($), 2011-2018 48
Table 29: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase, 2012 49
Table 30: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue ($m), 2007-2011 51
Table 31: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2011-2018 51
Table 32: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 53
Table 33: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 54
Table 34: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue ($m), 2007-2011 55
Table 35: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2011-2018 55
Table 36: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination ($), 2007-2011 56
Table 37: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 56
Table 38: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 56
Table 39: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 56
Table 40: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination ($), 2007-2011 57
Table 41: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 57
Table 42: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase, 2012 59
Table 43: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue ($m), 2007-2011 61
Table 44: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2011-2018 61
Table 45: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 62
Table 46: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 63
Table 47: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination ($), 2007-2011 64
Table 48: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 64
Table 49: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 64
Table 50: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 64
Table 51: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase, 2012 65
Table 52: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue ($m), 2007-2011 67
Table 53: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2011-2018 67
Table 54: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 68
Table 55: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 69
Table 56: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010-2018 70
Table 57: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination ($), 2007-2011 71
Table 58: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 71
Table 59: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 71
Table 60: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 71
Table 61: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Cost of Vaccination Forecast ($), 2009-2018 72
Table 62: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012 74
Table 63: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue ($m), 2007-2011 76
Table 64: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2011-2018 76
Table 65: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 77
Table 66: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 78
Table 67: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue ($m), 2007-2011 79
Table 68: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2011-2018 79
Table 69: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination ($), 2007-2011 80
Table 70: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 80
Table 71: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 80
Table 72: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 80
Table 73: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination ($), 2007-2011 81
Table 74: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 81
Table 75: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase, 2012 83
Table 76: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue ($m), 2007-2011 86
Table 77: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2011-2018 86
Table 78: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 87
Table 79: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 88
Table 80: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination ($), 2007-2011 88
Table 81: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 88
Table 82: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 89
Table 83: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 89
Table 84: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue ($m), 2007-2011 91
Table 85: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2011-2018 91
Table 86: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Revenue Forecast ($m), 2011-2018 91
Table 87: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination ($), 2007-2011 91
Table 88: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 91
Table 89: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Cost of Vaccination Forecast ($), 2012-2018 92
Table 90: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase, 2012 92
Table 91: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue ($m), 2007-2011 94
Table 92: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2011-2018 94
Table 93: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 95
Table 94: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 95
Table 95: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue ($m), 2007-2011 96
Table 96: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2011-2018 96
Table 97: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination ($), 2007-2011 97
Table 98: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 97
Table 99: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 97
Table 100: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 97
Table 101: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Cost of Vaccination ($), 2007-2011 98
Table 102: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 98
Table 103: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Global, Pipeline by Phase, 2012 98

List of Figures

Figure 1: Adult and Adolescent Vaccines Market to 2018, Global, Types of Vaccines, 2012 16
Figure 2: Adult and Adolescent Vaccines Market to 2018, The US, Recommendations for Immunization (19-65+ Years), 2012 17
Figure 3: Adult and Adolescent Vaccines Market to 2018, the US, Recommendations for Immunization (7-18 Years), 2012 18
Figure 4: Adult and Adolescent Vaccines Market to 2018, Top Five European Countries, Recommendations for Immunization, 2012 19
Figure 5: Adult and Adolescent Vaccines Market to 2018, Japan, Recommendations for Immunization (Under 20 Years of Age), 2011 20
Figure 6: Adult and Adolescent Vaccines Market to 2018, Global, Vaccine Manufacturing Process, 2012 24
Figure 7: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2007-2018 25
Figure 8: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Type of Vaccines (%), 2011 27
Figure 9: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Geography (%), 2011 28
Figure 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue Forecast ($m), 2007-2018 32
Figure 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 34
Figure 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2007-2018 36
Figure 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase (%), 2012 39
Figure 14: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2007-2018 43
Figure 15: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2007-2018 44
Figure 16: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2007-2018 46
Figure 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase (%), 2012 49
Figure 18: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2007-2018 51
Figure 19: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 53
Figure 20: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2007-2018 55
Figure 21: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase (%), 2012 58
Figure 22: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2007-2018 61
Figure 23: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 62
Figure 24: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase (%), 2012 65
Figure 25: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2007-2018 67
Figure 26: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 68
Figure 27: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010-2018 70
Figure 28: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012 73
Figure 29: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2007-2018 76
Figure 30: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 77
Figure 31: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2007-2018 79
Figure 32: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase (%), 2012 82
Figure 33: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2007-2018 86
Figure 34: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 87
Figure 35: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2007-2018 90
Figure 36: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase (%), 2012 92
Figure 37: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2007-2018 93
Figure 38: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 94
Figure 39: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2007-2018 96
Figure 40: Adult and Adolescent Vaccines Market to 2018, GSK, SWOT Analysis, 2012 100
Figure 41: Adult and Adolescent Vaccines Market to 2018, Sanofi, SWOT Analysis, 2012 101
Figure 42: Adult and Adolescent Vaccines Market to 2018, Pfizer, SWOT Analysis, 2012 102
Figure 43: Adult and Adolescent Vaccines Market to 2018, Merck, SWOT Analysis, 2012 103
Figure 44: Adult and Adolescent Vaccines Market to 2018, Novartis, SWOT Analysis, 2012 104
Figure 45: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Year, 2009-2012 105
Figure 46: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Type, 2009-2012 106
Figure 47: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Value, 2009-2012 107
Figure 48: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Geography, 2009-2012 108
Figure 49: GBI Research Market Forecasting Model 118

  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • Global Video Surveillance Market Driven by Increasing Demand for Security
    The global market for video surveillance has been witnessing steady growth with increase in demand for advanced surveillance systems by different law enforcement agencies. Increase in adoption of video surveillance by different sectors such as banking and finance, healthcare, transportation, and retail is one of the major drivers in the market. In 2013, the global [...]
  • Global Empty Capsules Market Driven by Growth in Pharmaceutical Industry
    With rapid growth in the pharmaceutical industry, the market for empty capsules has also grown at a steady pace. Some of the factors which are driving the growth of the empty capsules market are rise in aging population which is increasing the demand for capsule based drugs, technological advancement and increase in demand from the [...]
  • Global Aramid Fiber Industry to Witness High Growth in the Future
    With increasing use of aramid fibers in various industries, the global market for aramid fibers has grown significantly in recent years. Aramid fibers have a number of properties such as low density, heat resistance, high tensile strength, abrasion resistance, chemical resistance and impact resistance.  Asia-Pacific is the largest market for aramid fibers, followed by North [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Myasthenia Gravis – Pipeline Review, H2 2014
    Published: 10-Dec-2014        Price: US $2000 Onwards        Pages: 93
    Global Markets Direct's, ‘Myasthenia Gravis Pipeline Review, H2 2014', provides an overview of the Myasthenia Gravis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myasthenia Gravis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key......
  • Sarcoidosis – Pipeline Review, H2 2014
    Published: 10-Dec-2014        Price: US $2000 Onwards        Pages: 61
    Global Markets Direct's, ‘Sarcoidosis Pipeline Review, H2 2014', provides an overview of the Sarcoidosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved ......
  • Global Excipients Market 2014-2018
    Published: 3-Dec-2014        Price: US $2500 Onwards        Pages: 82
    Excipients are pharmacologically inactive substances used in the form of a carrier with the active ingredient of a medication. Excipients help stabilize the active ingredient of a drug for a longer period and are used as a bulking up agent in drug formulations. Excipients are classified primarily based on their product type, functionality, and category. The Global Excipients market is highly fragmented with multiple active vendors. TechNavio's analysts forecast the Global Excipients market to......
  • Osteoporosis Drugs Market in the APAC Region 2015-2019
    Published: 3-Dec-2014        Price: US $2500 Onwards        Pages: 73
    Osteoporosis is a disease that reduces of the mass and density of bone, and results in increased risk of fracture. In this disease, the risks related to fracture increases because of the increased permeability of the bones. Often, there are no symptoms observed until the first fracture occurs. Increase in age, low body weight, low sex hormones or menopause, and smoking are some of the risk factors associated with this disease. TechNavio's analysts forecast the Osteoporosis Drugs market in APA......
  • Global Multiple Myeloma Drugs Market 2015-2019
    Published: 3-Dec-2014        Price: US $3000 Onwards        Pages: 115
    Multiple myeloma is a common cancer that affects the plasma cells, a type of white blood cell. It begins in the plasma cells of bone marrow. The primary function of the plasma cells is to combat infections by producing antibodies, which attack germs after recognizing them. In multiple myeloma these plasma cells become malignant, it causes the production of a defective protein, which grows uncontrollably. This protein moves into the bones and cause tumors. Myeloma occurs when the malignant cells ......
  • Replagal-Drug Insights,2014
    Published: 2-Dec-2014        Price: US $1000 Onwards        Pages: 36
    Summary DelveInsight's pharmaceuticals report, "Replagal - Drug Insights, 2014" provides Replagal marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data......
  • Anti-Tumor Drugs Markets in China
    Published: 1-Dec-2014        Price: US $4000 Onwards        Pages: 187
    China's demand for Anti-Tumor Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Autoimmune Drugs Markets in China
    Published: 1-Dec-2014        Price: US $4000 Onwards        Pages: 173
    China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Hypertension Drugs Markets in China
    Published: 1-Dec-2014        Price: US $4000 Onwards        Pages: 186
    China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs